Founded in 2016, VivaVision Biotech is a clinical-stage R&D biopharmaceutical company. Our goal is to become the leading company of innovative medicines to treat topical diseases. We're focused on delivering new therapeis to millions of patients living with chronic ocular or dermal inflammatory diseases. We have an experienced team with a track record of success. Combining our world-class expertise and promising drug targets, we are able to create best-in-class and first-in-class therapeutics to fulfill the unmet medical needs.